What is the recommended dose and frequency of Intramuscular (IM) Compazine (prochlorperazine) for treating severe nausea and vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IM Prochlorperazine Dosing for Severe Nausea and Vomiting

For intramuscular administration in adults, inject 5 to 10 mg deeply into the upper outer quadrant of the buttock, repeating every 3 to 4 hours as needed, with a maximum total daily dose of 40 mg. 1

Standard IM Dosing Protocol

  • Initial dose: 5-10 mg IM injected deeply into the upper outer quadrant of the buttock 1
  • Frequency: Repeat every 3-4 hours if necessary 1
  • Maximum daily dose: Do not exceed 40 mg per day total IM dosage 1
  • Injection technique: Deep IM injection only; subcutaneous administration is not advisable due to local irritation 1

Special Population Considerations

Elderly and Debilitated Patients

  • Start at the lower end of the dosing range (5 mg) 1
  • Increase dosage more gradually than in younger patients 1
  • Monitor closely for hypotension and neuromuscular reactions, as elderly patients are more susceptible 1

Perioperative Use

  • Preoperative: 5-10 mg IM given 1-2 hours before anesthesia induction (may repeat once in 30 minutes if needed) 1
  • Intraoperative/Postoperative: 5-10 mg IM to control acute symptoms during or after surgery (repeat once if necessary) 1

Critical Safety Warnings

Extrapyramidal Reactions

  • Akathisia occurs in 16% of patients receiving prochlorperazine in the emergency department setting 2
  • Dystonia occurs in 4% of patients 2
  • These reactions typically develop within the first week of treatment 3
  • Consider prophylactic diphenhydramine 50 mg to prevent or treat dystonic reactions 4

Contraindications and Precautions

  • Absolute contraindications: CNS depression, concurrent use of adrenergic blockers 5
  • Avoid in pediatric surgery patients - children are more prone to extrapyramidal reactions even at moderate doses 1
  • Monitor for hypotension, particularly in unstable cardiac or trauma patients 1
  • QT prolongation risk: Repeated doses can prolong QT interval and potentially precipitate torsades de pointes 6

Comparative Efficacy

Prochlorperazine demonstrates superior antiemetic efficacy compared to promethazine in the emergency department setting:

  • Significantly faster symptom relief (mean 8.5 minutes for IV administration) 7
  • Lower treatment failure rate (9.5% vs 31% for promethazine) 8
  • Less sedation compared to promethazine (38% vs 71% reporting sleepiness) 8

Management of Refractory Symptoms

If nausea persists despite prochlorperazine:

  • Add a serotonin antagonist such as ondansetron 6
  • Consider adding dexamethasone for enhanced antiemetic effect 6
  • For palliative care patients, prochlorperazine 5-10 mg can be given 3-4 times daily (IV or oral routes) 5

Common Pitfalls to Avoid

  • Do not use subcutaneous route - causes local irritation 1
  • Do not mix with other agents in the syringe 1
  • Protect solution from light; discard if markedly discolored 1
  • Do not exceed 40 mg total daily dose to minimize risk of extrapyramidal effects and tardive dyskinesia with prolonged use 1, 9
  • Be vigilant for akathisia within the first week, as this is the most common extrapyramidal symptom (14% incidence) 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.